Nova Patents
LT3418281T

Pyrazolo[1,5-a]pyrimidines useful as inhibitors of atr kinase for the treatment of cancer diseases

Abstract

This record has no abstract on file.

Term

7.2 yearsto projected expiry

Projected expiry 6 December 2033, counted from filing; an application has no term until it is granted.

  1. Priority
  2. Filed
  3. Published
  4. Today
  5. Projected expiry

134 members in 32 offices

This recordMember, by publication datePriority claim22 more offices are in the list below

Priority claims12

Priority claims
DocumentOfficeKindDate
201261734726United States of AmericaP
201261734726United States of AmericaP
201361787568United States of AmericaP
201361787568United States of AmericaP
201361868132United States of AmericaP
201361868132United States of AmericaP
201261734726P–––
201361787568P–––
201361868132P–––
US201261734726P–––
US201361787568P–––
US201361868132P–––

Members134

Family members, oldest first
DocumentOfficeKind
CA2892608A1CanadaA1
US2014163000A1United States of AmericaA1
WO2014089379A1World Intellectual Property Organization (WIPO)A1
US2014249157A1United States of AmericaA1
TW201434839ATaiwan Province of ChinaA
WO2014089379A9World Intellectual Property Organization (WIPO)A9
AU2013355124A1AustraliaA1
IL239218A0IsraelA0
IL239218D0IsraelD0
SG11201504467YASingaporeA
KR20150091171ARepublic of KoreaA
CN104903325AChinaA
MX2015007101AMexicoA
EP2941432A1European Patent Office (EPO)A1
JP2016501244AJapanA
AR097128A1ArgentinaA1
HK1209746AHong Kong, ChinaA
HK1209746A1Hong Kong, ChinaA1
US9340546B2United States of AmericaB2
SG10201606373XASingaporeA
ZA201503871BSouth AfricaB
US2016347754A1United States of AmericaA1
HK1217190AHong Kong, ChinaA
HK1217190A1Hong Kong, ChinaA1
RU2015127079ARussian FederationA
US9650381B2United States of AmericaB2
NZ630457ANew ZealandA
BR112015012454A2BrazilA2
US9718827B2United States of AmericaB2
CN104903325BChinaB
CN107501274AChinaA
CN107501275AChinaA
CN107629059AChinaA
EP2941432B1European Patent Office (EPO)B1
US2018072735A1United States of AmericaA1
TWI618706BTaiwan Province of ChinaB
AU2013355124B2AustraliaB2
ES2669423T3SpainT3
PT2941432TPortugalT
JP2018087213AJapanA
US2018155346A1United States of AmericaA1
LT2941432TLithuaniaT
DK2941432T3DenmarkT3
TR2018007740T4TürkiyeT4
TR201807740T4TürkiyeT4
EP2941432B8European Patent Office (EPO)B8
AU2018204431A1AustraliaA1
HRP20180859T1CroatiaT1
SMT201800279T1San MarinoT1
RS57210B1SerbiaB1
SI2941432T1SloveniaT1
HUE037371T2HungaryT2
PL2941432T3PolandT3
JP6401709B2JapanB2
ME03036BMontenegroB
EP3418281A1European Patent Office (EPO)A1
IL263262D0IsraelD0
NZ731337ANew ZealandA
EP3486245A1European Patent Office (EPO)A1
RU2689996C2Russian FederationC2
CY1120232T1CyprusT1
IL263262AIsraelA
IL263262BIsraelB
US10392391B2United States of AmericaB2
JP6574859B2JapanB2
MX368042BMexicoB
BR112015012454A8BrazilA8
CN107501274BChinaB
CN107501275BChinaB
ZA201605990BSouth AfricaB
AU2018204431B2AustraliaB2
US2020140441A1United States of AmericaA1
CN107629059BChinaB
US10787452B2United States of AmericaB2
EP3418281B1European Patent Office (EPO)B1
DK3418281T3DenmarkT3
PT3418281TPortugalT
LT3418281TThis recordLithuaniaT
KR102213986B1Republic of KoreaB1
US2021047333A1United States of AmericaA1
HRP20202058T1CroatiaT1
RS61319B1SerbiaB1
SI3418281T1SloveniaT1
SMT202000713T1San MarinoT1
EP3808749A1European Patent Office (EPO)A1
EP3486245B1European Patent Office (EPO)B1
HUE052808T2HungaryT2
ES2842876T3SpainT3
DK3486245T3DenmarkT3
PT3486245TPortugalT
LT3486245TLithuaniaT
RS62174B1SerbiaB1
SMT202100425T1San MarinoT1
US11117900B2United States of AmericaB2
SI3486245T1SloveniaT1
CA2892608CCanadaC
PL3486245T3PolandT3
ES2884030T3SpainT3
HRP20211034T1CroatiaT1
HUE055618T2HungaryT2
Showing 100 of 134